RHÖN-KLINIKUM Aktiengesellschaft (RHK.DE)
EUR 13.8
(-1.43%)
EUR 13.8
(-1.43%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 116.58 Million EUR | -57.42% |
| 2022 | 106.15 Million EUR | 6.95% |
| 2021 | 100.2 Million EUR | 22.15% |
| 2020 | 80.66 Million EUR | -34.73% |
| 2019 | 125.56 Million EUR | -0.41% |
| 2018 | 125.64 Million EUR | 16.57% |
| 2017 | 97.03 Million EUR | -35.27% |
| 2016 | 158.1 Million EUR | 0.73% |
| 2015 | 158.21 Million EUR | 100.93% |
| 2014 | 1.42 Billion EUR | -71.92% |
| 2013 | 279.09 Million EUR | -5.52% |
| 2012 | 298.82 Million EUR | -12.35% |
| 2011 | 364.86 Million EUR | 12.7% |
| 2010 | 308.45 Million EUR | 9.37% |
| 2009 | 288.82 Million EUR | 6.83% |
| 2008 | 270.34 Million EUR | -53.87% |
| 2007 | 254.52 Million EUR | 3.54% |
| 2006 | 566.09 Million EUR | 37.76% |
| 2005 | 410.91 Million EUR | 32.54% |
| 2004 | 310.01 Million EUR | 90.2% |
| 2003 | 162.99 Million EUR | 3.02% |
| 2002 | 158.22 Million EUR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 23.91 Million EUR | -4.86% |
| 2024 Q1 | 25.14 Million EUR | -32.32% |
| 2023 Q4 | 32.01 Million EUR | 0.76% |
| 2023 Q1 | 24.29 Million EUR | -19.64% |
| 2023 Q3 | 31.77 Million EUR | 26.64% |
| 2023 FY | - EUR | -57.42% |
| 2023 Q2 | 25.09 Million EUR | 3.27% |
| 2022 Q1 | 19.98 Million EUR | -31.25% |
| 2022 Q2 | 33.06 Million EUR | 65.43% |
| 2022 FY | - EUR | 6.95% |
| 2022 Q3 | 23.98 Million EUR | -27.44% |
| 2022 Q4 | 30.23 Million EUR | 26.04% |
| 2021 Q2 | 27.16 Million EUR | 38.44% |
| 2021 Q3 | 24.51 Million EUR | -9.75% |
| 2021 Q4 | 29.06 Million EUR | 18.58% |
| 2021 Q1 | 19.61 Million EUR | -4.33% |
| 2021 FY | - EUR | 22.15% |
| 2020 FY | - EUR | -34.73% |
| 2020 Q3 | 26 Million EUR | 22.33% |
| 2020 Q4 | 20.5 Million EUR | -21.13% |
| 2020 Q2 | 21.25 Million EUR | 47.56% |
| 2020 Q1 | 14.4 Million EUR | -48.2% |
| 2019 Q1 | 28.9 Million EUR | 22.91% |
| 2019 FY | - EUR | -0.41% |
| 2019 Q2 | 32.48 Million EUR | 12.39% |
| 2019 Q3 | 36.68 Million EUR | 12.95% |
| 2019 Q4 | 27.8 Million EUR | -24.2% |
| 2018 Q2 | 23.73 Million EUR | -16.1% |
| 2018 Q3 | 51.18 Million EUR | 115.64% |
| 2018 Q4 | 23.51 Million EUR | -54.06% |
| 2018 Q1 | 28.29 Million EUR | 24.52% |
| 2018 FY | - EUR | 16.57% |
| 2017 Q3 | 27.4 Million EUR | 10.84% |
| 2017 FY | - EUR | -35.27% |
| 2017 Q4 | 22.72 Million EUR | -17.1% |
| 2017 Q2 | 24.72 Million EUR | -14.39% |
| 2017 Q1 | 28.88 Million EUR | 1.7% |
| 2016 Q1 | 70.45 Million EUR | 67.79% |
| 2016 Q2 | 36.06 Million EUR | -48.81% |
| 2016 Q3 | 28.47 Million EUR | -21.04% |
| 2016 Q4 | 28.39 Million EUR | -0.28% |
| 2016 FY | - EUR | 0.73% |
| 2015 Q2 | 35.07 Million EUR | -33.4% |
| 2015 Q1 | 52.66 Million EUR | 352.99% |
| 2015 FY | - EUR | 100.93% |
| 2015 Q4 | 41.99 Million EUR | 22.11% |
| 2015 Q3 | 34.38 Million EUR | -1.95% |
| 2014 Q4 | 11.62 Million EUR | -56.39% |
| 2014 Q2 | -25.35 Million EUR | -137.38% |
| 2014 FY | - EUR | -71.92% |
| 2014 Q3 | 26.65 Million EUR | 205.12% |
| 2014 Q1 | 67.84 Million EUR | 16.14% |
| 2013 Q3 | 72.11 Million EUR | -7.3% |
| 2013 Q4 | 58.41 Million EUR | -19.0% |
| 2013 FY | - EUR | -5.52% |
| 2013 Q2 | 77.79 Million EUR | -1.87% |
| 2013 Q1 | 79.27 Million EUR | 2.79% |
| 2012 Q3 | 71.51 Million EUR | 9.08% |
| 2012 Q2 | 65.56 Million EUR | -22.06% |
| 2012 Q1 | 84.11 Million EUR | -3.93% |
| 2012 FY | - EUR | -12.35% |
| 2012 Q4 | 77.12 Million EUR | 7.84% |
| 2011 Q2 | 85.08 Million EUR | 5.24% |
| 2011 Q1 | 80.85 Million EUR | -0.11% |
| 2011 Q3 | 101.22 Million EUR | 18.97% |
| 2011 Q4 | 87.56 Million EUR | -13.5% |
| 2011 FY | - EUR | 12.7% |
| 2010 Q1 | 74.8 Million EUR | -2.29% |
| 2010 FY | - EUR | 9.37% |
| 2010 Q4 | 80.93 Million EUR | 2.54% |
| 2010 Q3 | 78.93 Million EUR | -1.34% |
| 2010 Q2 | 79.99 Million EUR | 6.94% |
| 2009 FY | - EUR | 6.83% |
| 2009 Q4 | 76.55 Million EUR | 8.52% |
| 2009 Q3 | 70.54 Million EUR | -4.74% |
| 2009 Q2 | 74.05 Million EUR | 9.46% |
| 2009 Q1 | 67.65 Million EUR | 0.0% |
| 2008 FY | - EUR | -53.87% |
| 2007 FY | - EUR | 3.54% |
| 2006 FY | - EUR | 37.76% |
| 2005 FY | - EUR | 32.54% |
| 2004 FY | - EUR | 90.2% |
| 2003 FY | - EUR | 3.02% |
| 2002 FY | - EUR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 2.93 Billion EUR | 96.026% |
| Fresenius SE & Co. KGaA | 2.73 Billion EUR | 95.737% |
| LIMES Schlosskliniken AG | 854.98 Thousand EUR | -13535.625% |
| M1 Kliniken AG | 21.79 Million EUR | -434.959% |
| Maternus-Kliniken Aktiengesellschaft | 4.71 Million EUR | -2372.577% |
| MEDICLIN Aktiengesellschaft | 101.26 Million EUR | -15.126% |
| VITA 34 AG | 5.8 Million EUR | -1907.957% |